Description

Cost-effectiveness considerations for probiotic co-administration with antibiotics are summarized, integrating AAD incidence rates with healthcare utilization data.

Figure 6

Source Paper

A practical guide for probiotics applied to the case of antibiotic-associated diarrhea in The Netherlands.

BMC gastroenterology (2018)

PMID: 30078376

DOI: 10.1186/s12876-018-0831-x

Cite This Figure

![Figure 6: Cost-effectiveness considerations for probiotic co-administration with antibiotics are summarized, integrating AAD incidence rates with healthcare utilization data.]()

> Source: Valeria Agamennone et al. "A practical guide for probiotics applied to the case of antibiotic-associated di." *BMC gastroenterology*, 2018. PMID: [30078376](https://pubmed.ncbi.nlm.nih.gov/30078376/)

<figure>
  <img src="" alt="Cost-effectiveness considerations for probiotic co-administration with antibiotics are summarized, integrating AAD incidence rates with healthcare utilization data." />
  <figcaption>Figure 6. Cost-effectiveness considerations for probiotic co-administration with antibiotics are summarized, integrating AAD incidence rates with healthcare utilization data.<br>  Source: Valeria Agamennone et al. "A practical guide for probiotics applied to the case of antibiotic-associated di." <em>BMC gastroenterology</em>, 2018. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/30078376/">30078376</a></figcaption>
</figure>

Related Evidence

Lactobacillus rhamnosus GG for Antibiotic-Associated Diarrhea (AAD)

Grade A · 20 studies